» Articles » PMID: 24708873

MiR-375 Activates P21 and Suppresses Telomerase Activity by Coordinately Regulating HPV E6/E7, E6AP, CIP2A, and 14-3-3ζ

Overview
Journal Mol Cancer
Publisher Biomed Central
Date 2014 Apr 9
PMID 24708873
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Background: While microRNAs (miRNAs) are extensively studied in post-transcriptional regulation of gene expressions in many biological processes, cellular miRNA-mediated regulation of viral genes remains unclear. In particular, the interplay between human papillomavirus (HPV) genes and miRNAs and how these interactions contribute to HPV-associated cancers remain elusive.

Methods: Transient transfection of miR-375-mimic was used to compensate the loss-of-function of miR-375 in HPV-positive cancer. Regulation of oncogenic molecules and their downstream molecules via miR-375 in HPV-positive cancer was investigated using qRT-PCR, western blot, dual luciferase assay, indirect immunofluorescence analysis. All experiments were conducted at least three times to achieve statistical significance determined by Student t-test.

Results: In this study, we demonstrated how miR-375 negatively regulates HPV16 and 18 transcripts. We also found a cellular protein, E6-associated protein (E6AP), directly regulated by miR-375. miR-375-mediated repression of HPV transcripts and E6AP elevated major tumor suppressors p53, p21, and retinoblastoma protein 1 (RB). Cooperative regulation of miR-375 targets along with the increase of tumor suppressors led to ~60% reduction of telomerase reverse transcriptase (TERT) transcription followed by ~35% decrease of telomerase activity. Furthermore, miR-375-mediated regulation of 14-3-3ζ contributes to decrease telomerase activity by altering nuclear translocation of TERT.

Conclusion: Taken together, miR-375-mediated suppression of multiple oncogenic components in HPV-associated carcinogenesis generates a cumulative biological response to rescue key tumor suppressors and diminish telomerase activity, which results in cell cycle arrest and cell proliferation inhibition.

Citing Articles

Interplay between epigenetics, senescence and cellular redox metabolism in cancer and its therapeutic implications.

Balamurli G, Liew A, Tee W, Pervaiz S Redox Biol. 2024; 78:103441.

PMID: 39612910 PMC: 11629570. DOI: 10.1016/j.redox.2024.103441.


MicroRNAs role in telomere length maintenance and telomerase activity in tumor cells.

Bortoletto S, Nunes-Souza E, Marchi R, Ruthes M, Okano L, Tofolo M J Mol Med (Berl). 2024; 102(9):1089-1100.

PMID: 39042290 DOI: 10.1007/s00109-024-02467-z.


Protein Phosphatase 2A as a Therapeutic Target in Pulmonary Diseases.

Yu H, Zaveri S, Sattar Z, Schaible M, Perez Gandara B, Uddin A Medicina (Kaunas). 2023; 59(9).

PMID: 37763671 PMC: 10535831. DOI: 10.3390/medicina59091552.


Small Molecule Inhibitors of Human Papillomavirus: A Review of Research from 1997 to 2021.

Duncan C, Gunosewoyo H, Mocerino M, Payne A Curr Med Chem. 2023; 31(33):5308-5350.

PMID: 37448363 DOI: 10.2174/0929867331666230713165407.


From Basic Science to Clinical Practice: The Role of Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A)/p90 in Cancer.

Chen B, Hu H, Chen X Front Genet. 2023; 14:1110656.

PMID: 36911405 PMC: 9998691. DOI: 10.3389/fgene.2023.1110656.


References
1.
Zheng Z, Tao M, Yamanegi K, Bodaghi S, Xiao W . Splicing of a cap-proximal human Papillomavirus 16 E6E7 intron promotes E7 expression, but can be restrained by distance of the intron from its RNA 5' cap. J Mol Biol. 2004; 337(5):1091-108. DOI: 10.1016/j.jmb.2004.02.023. View

2.
McCance D, Kopan R, Fuchs E, Laimins L . Human papillomavirus type 16 alters human epithelial cell differentiation in vitro. Proc Natl Acad Sci U S A. 1988; 85(19):7169-73. PMC: 282145. DOI: 10.1073/pnas.85.19.7169. View

3.
Chang T, Yu D, Lee Y, Wentzel E, Arking D, West K . Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet. 2007; 40(1):43-50. PMC: 2628762. DOI: 10.1038/ng.2007.30. View

4.
Kanaya T, Kyo S, Hamada K, Takakura M, Kitagawa Y, Harada H . Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription. Clin Cancer Res. 2000; 6(4):1239-47. View

5.
Niculescu 3rd A, Chen X, Smeets M, Hengst L, Prives C, Reed S . Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol Cell Biol. 1998; 18(1):629-43. PMC: 121530. DOI: 10.1128/MCB.18.1.629. View